Cargando…

Patterns of Anticoagulation Use and Cardioembolic Risk After Catheter Ablation for Atrial Fibrillation

BACKGROUND: There is significant practice variation in oral anticoagulation (OAC) use following catheter ablation for atrial fibrillation. It is not clear whether the risk of cardioembolism increases after discontinuation of OAC following catheter ablation. METHODS AND RESULTS: We identified 6886 pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Noseworthy, Peter A., Yao, Xiaoxi, Deshmukh, Abhishek J., Van Houten, Holly, Sangaralingham, Lindsey R., Siontis, Konstantinos C., Piccini, Jonathan P., Asirvatham, Samuel J., Friedman, Paul A., Packer, Douglas L., Gersh, Bernard J., Shah, Nilay D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2015
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4845220/ https://www.ncbi.nlm.nih.gov/pubmed/26541393 http://dx.doi.org/10.1161/JAHA.115.002597

Ejemplares similares

Effect of Adherence to Oral Anticoagulants on Risk of Stroke and Major Bleeding Among Patients With Atrial Fibrillation
por: Yao, Xiaoxi, et al.
Publicado: (2016)

Contemporary trends and barriers to oral anticoagulation therapy in Non-valvular atrial fibrillation during DOAC predominant era
por: Sehrawat, Ojasav, et al.
Publicado: (2023)

Catheter-related complications and mortality of atrial fibrillation ablation following introduction of contact force-sensing technology
por: Akar, Joseph G, et al.
Publicado: (2020)

Ischemic Stroke or Systemic Embolism After Transseptal Ablation of Arrhythmias in Patients With Cardiac Implantable Electronic Devices
por: Madhavan, Malini, et al.
Publicado: (2016)

Anticoagulation for Stroke Prevention in Older Adults with Atrial Fibrillation and Comorbidity: Current Evidence and Treatment Challenges
por: Sabbag, Avi, et al.
Publicado: (2018)

Generalizability of the EAST‐AFNET 4 Trial: Assessing Outcomes of Early Rhythm‐Control Therapy in Patients With Atrial Fibrillation
por: Dickow, Jannis, et al.
Publicado: (2022)

Baseline characteristics and event rates among anticoagulated patients with atrial fibrillation in practice and pivotal NOAC trials
por: Noseworthy, Peter A., et al.
Publicado: (2017)

Percutaneous Left Atrial Appendage Occlusion in Comparison to Non‐Vitamin K Antagonist Oral Anticoagulant Among Patients With Atrial Fibrillation
por: Noseworthy, Peter A., et al.
Publicado: (2022)

Diagnosis-to-ablation time predicts recurrent atrial fibrillation and rehospitalization following catheter ablation
por: Chew, Derek S., et al.
Publicado: (2021)

On-treatment follow-up in real-world studies of direct oral anticoagulants in atrial fibrillation: Association with treatment effects
por: Hutto, David, et al.
Publicado: (2022)

Cavotricuspid isthmus ablation for atrial flutter: Anatomic challenges and troubleshooting
por: Christopoulos, Georgios, et al.
Publicado: (2020)

Evaluation and Catheter Ablation of Ventricular Arrhythmias in Cardiac Sarcoidosis
por: Ezzeddine, Fatima M., et al.
Publicado: (2022)

Intra-procedural anticoagulation protocols for left-sided cardiac ablations: Striking a balance between risk and benefit
por: Siontis, Konstantinos C.
Publicado: (2016)

Acute Cardioembolic Stroke in the Setting of Subtherapeutic Anticoagulation
por: Ambatipudi, Ankit, et al.
Publicado: (2023)

Hybrid Catheter-Based and Surgical Techniques for Ablation of Ventricular Arrhythmias
por: Khalil, Fouad, et al.
Publicado: (2020)

Is Atrial Fibrillation Management as Simple as ABC?
por: Yao, Xiaoxi, et al.
Publicado: (2020)

Catheter ablation of atrial fibrillation in patients with and without hypertrophic cardiomyopathy: systematic review and meta-analysis
por: Ezzeddine, Fatima M, et al.
Publicado: (2023)

QRS complex maximum deflection index in aortic cusp premature ventricular complexes
por: Siontis, Konstantinos C., et al.
Publicado: (2015)

Is Anticoagulation Necessary for Severely Disabled Cardioembolic Stroke Survivors?
por: Jurjans, Kristaps, et al.
Publicado: (2019)

Assessment of Trends in Statin Therapy for Secondary Prevention of Atherosclerotic Cardiovascular Disease in US Adults From 2007 to 2016
por: Yao, Xiaoxi, et al.
Publicado: (2020)

Effectiveness and Safety of Dabigatran, Rivaroxaban, and Apixaban Versus Warfarin in Nonvalvular Atrial Fibrillation
por: Yao, Xiaoxi, et al.
Publicado: (2016)

Oral anticoagulation in elderly patients as secondary prevention of cardioembolic strokes
por: Benavente, Lorena, et al.
Publicado: (2010)

Impact of Anticoagulants in Reducing Mortality and Disability in Cardioembolic Stroke Patients
por: Jurjāns, Kristaps, et al.
Publicado: (2022)

Healthcare utilization and cost in patients with atrial fibrillation and heart failure undergoing catheter ablation
por: Field, Michael E., et al.
Publicado: (2020)

Development and validation pathways of artificial intelligence tools evaluated in randomised clinical trials
por: Siontis, George C M, et al.
Publicado: (2021)

Artificial intelligence-enhanced electrocardiography in cardiovascular disease management
por: Siontis, Konstantinos C., et al.
Publicado: (2021)

Recurrent cryptogenic stroke: A potential role for an artificial intelligence–enabled electrocardiogram?
por: Kashou, Anthony H., et al.
Publicado: (2020)

Early recurrence of ischaemic stroke of cardioembolic cause and delayed anticoagulation: a case report
por: Aghetti, Agnes, et al.
Publicado: (2022)

Atrial Fibrillation and Cancer: Where Biology and Epidemiology Intertwine
por: Siontis, Konstantinos C., et al.
Publicado: (2021)

Outcomes and Resource Utilization Associated With Readmissions After Atrial Fibrillation Hospitalizations
por: Tripathi, Byomesh, et al.
Publicado: (2019)

Report of periprocedural oral anticoagulants in catheter ablation for atrial fibrillation: The Japanese Catheter Ablation Registry of Atrial Fibrillation (J-CARAF)
por: Murakawa, Yuji, et al.
Publicado: (2017)

Oral Anticoagulation Discontinuation Following Catheter Ablation of Typical Atrial Flutter
por: Alqam, Bilal M., et al.
Publicado: (2021)

Comparison of phenprocoumon with direct oral anticoagulants in catheter ablation of atrial fibrillation
por: Gjermeni, Diona, et al.
Publicado: (2023)

Catheter ablation and healthcare utilization and cost among patients with paroxysmal versus persistent atrial fibrillation
por: Friedman, Daniel J., et al.
Publicado: (2020)

Catheter ablation of atrial fibrillation: recent advances and future challenges
por: Hindricks, Gerhard, et al.
Publicado: (2022)

Oral anticoagulant use and the development of new cerebral microbleeds in cardioembolic stroke patients with atrial fibrillation
por: Umemura, Toshitaka, et al.
Publicado: (2020)

Cardioembolic stroke with hemorrhagic transformation in atrial fibrillation patients on anticoagulant therapy: A case report
por: Wulandari, Wulandari, et al.
Publicado: (2023)

Platelet function suggests cardioembolic aetiology in cryptogenic stroke
por: Dev, Priya, et al.
Publicado: (2023)

Comparative Effectiveness of Anticoagulants in Patients With Cancer-Associated Thrombosis
por: Riaz, Irbaz Bin, et al.
Publicado: (2023)

Cardioembolic stroke: everything has changed
por: Spence, J David
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_fccfch8snos74umth6kkjvrvoe